British pharma giant GSK to acquire US drug developer IDRx in $1.15 billion deal




The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More



Source link

  • Related Posts

    Marco Rubio, nominee for Secretary of State, to argue that China ‘cheated’ and ‘hacked’ its way to ‘global superpower status’ at hearing

    “The postwar global order is not just obsolete; it is now a weapon being used against us,” Rubio said, according to prepared remarks. Read More Source link

    Pete Hegseth wants warriors, preparation and lethality above all else

    FOX Business host Larry Kudlow reacts to confirmation hearings for Trump’s defense secretary nominee on “Kudlow.” Pete Hegseth shone today in his 4+ hour long hearing to become Defense Secretary.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *